HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
$6.40
Makalipas ang Oras ng Trabaho:(0.31%)+0.020
$6.42
Sarado: Ene 10, 8:00:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$7.17
Sakop ng araw
$6.24 - $7.03
Sakop ng taon
$6.24 - $18.33
Market cap
1.95B USD
Average na Volume
6.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 58.56M | 12,385.07% |
Gastos sa pagpapatakbo | 107.80M | -5.85% |
Net na kita | -83.54M | 26.56% |
Net profit margin | -142.67 | 99.41% |
Kita sa bawat share | -0.28 | 39.13% |
EBITDA | -80.50M | 27.76% |
Aktuwal na % ng binabayarang buwis | 1.79% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 397.49M | 9.99% |
Kabuuang asset | 991.12M | 16.29% |
Kabuuang sagutin | 217.66M | 22.07% |
Kabuuang equity | 773.46M | — |
Natitirang share | 304.78M | — |
Presyo para makapag-book | 2.82 | — |
Return on assets | -22.77% | — |
Return on capital | -26.16% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -83.54M | 26.56% |
Cash mula sa mga operasyon | -58.97M | 29.86% |
Cash mula sa pag-invest | -48.80M | 38.24% |
Cash mula sa financing | 41.95M | -79.31% |
Net change in cash | -64.57M | -271.22% |
Malayang cash flow | -22.87M | 50.68% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
557
